Skip to main content

Prosthetic-joint Infection

0
Pipeline Programs
3
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
2 programs
Semi-quantitative electrochemical leukocyte esterse test stripN/A1 trial
Surgiphor Irrigation SolutionN/A1 trial
Active Trials
NCT05440032Unknown160Est. Mar 2024
NCT05434260Unknown868Est. Jan 2025
Osteal Therapeutics
2 programs
VT-X7 Treatment SystemN/A1 trial
VT-X7 Treatment SystemPHASE_21 trial
Active Trials
NCT06383611Temporarily Not Available
NCT05607030Completed76Est. Oct 2024
Peptilogics
PeptilogicsPA - Pittsburgh
1 program
PLG0206PHASE_2_31 trial
Active Trials
NCT07214311Recruiting240Est. Sep 2028

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
PeptilogicsPLG0206
Osteal TherapeuticsVT-X7 Treatment System
Innovation PharmaceuticalsSemi-quantitative electrochemical leukocyte esterse test strip
Innovation PharmaceuticalsSurgiphor Irrigation Solution

Clinical Trials (5)

Total enrollment: 1,344 patients across 5 trials

NCT07214311PeptilogicsPLG0206

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

Start: Feb 2026Est. completion: Sep 2028240 patients
Phase 2/3Recruiting
NCT05607030Osteal TherapeuticsVT-X7 Treatment System

A Second Trial of the Abbreviated Protocol Two-Stage Exchange

Start: Jan 2023Est. completion: Oct 202476 patients
Phase 2Completed
NCT06383611Osteal TherapeuticsVT-X7 Treatment System

Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

N/ATemporarily Not Available
NCT05440032Innovation PharmaceuticalsSemi-quantitative electrochemical leukocyte esterse test strip

LE as a Marker for Periprosthetic Joint Infection

Start: Dec 2023Est. completion: Mar 2024160 patients
N/AUnknown
NCT05434260Innovation PharmaceuticalsSurgiphor Irrigation Solution

Surgiphor vs Saline Joints

Start: Sep 2022Est. completion: Jan 2025868 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,344 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.